Syndax Pharmaceuticals Inc·4

May 19, 4:03 PM ET

Botwood Nicholas A.J. 4

4 · Syndax Pharmaceuticals Inc · Filed May 19, 2025

Insider Transaction Report

Form 4
Period: 2025-05-16
Botwood Nicholas A.J.
Head of R&D, CMO
Transactions
  • Purchase

    Common Stock

    2025-05-16$8.99/sh+11,765$105,82635,165 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4